Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: August 6, 2003
Last updated: March 16, 2015
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)